1. Fisher B, Bryant J, Wolmark N,et al: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.J Gin Oncol 16: 2672–2685, 1998.
2. Nishimura R, Nagao K, Miyayama H,et al: Predictive value of proliferative activity for response to chemotherapy or endocrine therapy in advanced or recurrent breast cancer.Jpn J Breast Cancer 12: 219–224, 1997 (in Japanese with English abstract).
3. Nishimura R, Nagao K, Miyayama H,et al: Studies on relationships between the effect and prognosis in chemo-endocrine therapy as a first- or second-line treatment for advanced or recurrent breast cancer.Jpn J Breast Cancer 15: 309–316, 2000 (in Japanese with English abstract).
4. Paik S, Bryant J, Park C,et al: erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer.J Natl Cancer Inst 18: 1361–1370, 1998.
5. Nishimura R, Nagao K, Miyayama H: Studies on Correlation of Positive Surgical Margin with Clinicopathological Factors and Prognoses in Breast Conserving Surgery.Jpn J Breast Cancer 14: 219–224, 1999 (in Japanese with English abstract).